Pre-symptomatic increase in urine-orosomucoid excretion in pre-eclamptic women

References

• Hubel C. Oxidative stress in the pathogenesis of preeclampsia. PSEBM. 1999; 222: 222–35
   PubMed Web of Science ®Google Scholar
• Roberts J, Lain K. Recent insights into the pathogenesis of preeclampsia. Placenta. 2002; 23: 359–72
   PubMed Web of Science ®Google Scholar
• Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta. 2006; 27: 939–58
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161: 1200–4
   PubMed Web of Science ®Google Scholar
• Roberts J, Cooper D. Pathogenesis and genetics of preeclampsia. Lancet. 2001; 357: 53–6
   PubMed Web of Science ®Google Scholar
• Redman CWG, Sargent IL. Placental debris, oxidative stress and preeclampsia. Placenta. 2002; 21: 597–602
   Web of Science ®Google Scholar
• Conde-Agudelo A, Villar J, Lindheimer M. World health organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004; 104: 1367–91
   PubMed Web of Science ®Google Scholar
• Tjoa ML, Oudejans CBM, van Vugt JMG, Blankenstein MA, vanWijk I. Markers for presymptomatic prediction of preeclampsia and interuterine growth restriction. Hypertens Pregnancy. 2004; 23: 171–89
   PubMed Web of Science ®Google Scholar
• Becker R, Vonk R, Vollert W, Entezami M. Doppler sonography of uterine arteries at 20–23 weeks: risk assessment of adverse pregnancy outcome by quantification of impedance and notch. J Perinat Med. 2002; 30(5)388–94
   PubMed Web of Science ®Google Scholar
• Fournier T, Medjoubi N, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000; 1482(1–2)157–71
   PubMed Web of Science ®Google Scholar
• Sörensson J, Matejka GL, Ohlson M, Haraldsson B. Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am J Physiol. 1999; 276: 530–4
   PubMed Web of Science ®Google Scholar
• Denk A, Goebeler M, Schmid S, Berberich I, Ritz O, Lindemann D, et al. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem. 2001; 276(30)28451–8
   PubMed Web of Science ®Google Scholar
• Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in cascular endothelial cells. FASEB J. 2001; 15: 279–281
   PubMed Web of Science ®Google Scholar
• Weber C, Erl W. Modulation of vascular cell activation, function, and apoptosis: role of antioxidants and NF-kappaB, 2000: 217. Academic Press.
   Google Scholar
• Logdberg L, Wester L. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta. 2000; 1482(1–2)284–97
   PubMed Web of Science ®Google Scholar
• Krauer B, Dayer P, Anner R. Changes in serum albumin and alpha1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynecol. 1984; 91: 875–81
   PubMedGoogle Scholar
• Honda M, Omori Y, Minei S, Oshiyana T, Shimizu M, Sanaka M. Quantitative analysis of serum alpha1-acid glycoprotein levels in normal and diabetic pregnancy. Diabetes Res Clin Pract. 1990; 10: 147–52
   PubMed Web of Science ®Google Scholar
• Haram K, Augesen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute phase reactants. Br J Obstet Gynecol. 1983; 90: 139–45
   PubMedGoogle Scholar
• Good W. Maternal serum sialomucins during pregnancy and postpartum in patients with preeclampsia. Br J Obstet Gynecol. 1975; 82: 907–16
   PubMedGoogle Scholar
• Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999; 353(9165)1649–52
   PubMed Web of Science ®Google Scholar
• Christiansen MS, Hommel E, Magid E, Feldt-Rasmussen B. Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes. Diabetologia. 2002; 45(1)115–20
   PubMed Web of Science ®Google Scholar
• Christiansen MS, Hommel E, Magid E, Feldt-Rasmussen B. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up. Diabetologia. 2005; 48(2)386–93
   PubMed Web of Science ®Google Scholar
• Narita T, Sasaki H, Hosoba M, Miura T, Yoshioka N, Morii T, et al. Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes Care. 2004; 27(5)1176–81
   PubMed Web of Science ®Google Scholar
• Vittinghus E. Preanalytical handling of stored urine samples, and measurement of beta 2-microglobulin, orosomucoid, albumin, transferrin and immunoglobulin G in urine by enzyme-linked immunosorbent assays (ELISA). Scand J Clin Lab Invest. 1990; 50(8)843–9
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005; 365(9461)785–99
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int. 2005; 67(6)2101–13
   PubMed Web of Science ®Google Scholar
• Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy. 2003; 22(2)129–41
   PubMed Web of Science ®Google Scholar
• Conrad KP, Novak J, Danielson LA, Kerchner LJ, Jeyabalan A. Mechanisms of renal vasodilation and hyperfiltration during pregnancy: current perspectives and potential implications for preeclampsia. Endothelium. 2005; 12(1–2)57–62
   PubMed Web of Science ®Google Scholar
• Moran P, Baylis PH, Lindheimer MD, Davison JM. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol. 2003; 14(3)648–52
   PubMed Web of Science ®Google Scholar
• Moran P, Lindheimer MD, Davison JM. The renal response to preeclampsia. Semin Nephrol. 2004; 24(6)588–95
   PubMed Web of Science ®Google Scholar
• Drumond MC, Kristal B, Myers BD, Deen WM. Structural basis for reduced glomerular filtration capacity in nephrotic humans. J Clin Invest. 1994; 94(3)1187–95
   PubMed Web of Science ®Google Scholar
• Lafayette RA, Druzin M, Sibley R, Derby G, Malik T, Huie P, et al. Nature of glomerular dysfunction in pre-eclampsia. Kidney Int. 1998; 54(4)1240–9
   PubMed Web of Science ®Google Scholar
• Naicker T, Randeree IG, Moodley J, Khedun SM, Ramsaroop R, Seedat YK. Correlation between histological changes and loss of anionic charge of the glomerular basement membrane in early-onset pre-eclampsia. Nephron. 1997; 75(2)201–7
   PubMed Web of Science ®Google Scholar
• Koshimura J, Narita T, Sasaki H, Hosoba M, Yoshioka N, Shimotomai T, et al. Urinary excretion of transferrin and orosomucoid are increased after acute protein loading in healthy subjects. Nephron Clin Pract. 2005; 100(2)c33–c37
   PubMedGoogle Scholar
• Tencer J, Thysell H, Grubb A. Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest. 1996; 56(8)691–700
   PubMed Web of Science ®Google Scholar
• Magid E, Guldager H, Hesse D, Christiansen MS. Monitoring urinary orosomucoid in acute inflammation: observations on urinary excretion of orosomucoid, albumin, alpha1-microglobulin, and IgG. Clin Chem. 2005; 51(11)2052–8
   PubMed Web of Science ®Google Scholar